Murine γ/δ-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

Blood

Volumn 87, Issue 10, 1996, Pages 4463-4472

  Blazar, Bruce R ^a   Taylor, Patricia A ^b   Bluestone, Jeffrey A ^b   Vallera, Daniel A ^b  

^a UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOLYSIS; GENE EXPRESSION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE;

EID: 0029878602     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.10.4463.bloodjournal87104463     Document Type: Article

References (56)

1. Kernan NA: T-cell depletion for prevention of graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell Scientific, 1994, p 124
2. Davies SM, Weisdorf DJ, Haake RJ, Kersey JH, McGlave PB, Ramsay NKC, Blazar BR: Second infusion of bone marrow for the treatment of graft failure after allogeneic bone marrow transplantation. Bone Marrow Transplant 14:73, 1994
3. Donahue J, Homge M, Kernan NA: Characterization of cells emerging at the time of graft failure after bone marrow transplantation from an unrelated marrow donor. Blood 82:1023, 1993
4. Sondel PM, Hank JA, Trigg ME, Kohler PC, Finlay JL, Blank J, Meisner L, Borcherding W, Hong R, Steeves R, Billing R, Flynn B, Bozdech MJ: Transplantation of HLA-haploidentical T-cell-depleted marrow for leukemia: Autologous marrow recovery with specific immune sensitization to donor antigens. Exp Hematol 14:278, 1986
5. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ: Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 43:842, 1987
6. Bunjes D, Heit W, Arnold R, Schmeiser T, Wiesneth M, Carbonell F, Porzsolt F, Raghavachar A, Heimpel H: Evidence for the involvement of host-derived OKT8-positive T cells in the rejection of T-depleted, HLA-identical bone marrow grafts. Transplantation 43:501, 1987
7. Kedar E, Or R, Naparstek E, Zeira E, Slavin S: Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT). Bone Marrow Transplant 3:129, 1988
8. Bordignon C, Keever CA, Small TN, Flomenberg N, Dupont B, O'Reilly RJ, Kernan NA: Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms. Blood 74:2237, 1989
9. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY: Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818, 1990
10. Papadakis V, Mackinnon S, Kernan NA: Differential effect of pre-transplant cytoreduction on recovery of day zero host circulating cells. Bone Marrow Transplant 14:623, 1994
11. Lanier LL, Weiss AL: Presence of Ti (WT31) negative T lymphocytes in normal blood and thymus. Nature 324:268, 1986
12. Lanier LL, Federspiel NA, Ruitenberg JJ, Phillips JH, Allison JP, Littman D, Weiss A: The T cell antigen receptor complex expressed on normal peripheral blood CD4-, CD8-/T lymphocytes. A CD3 associated disulfide linked γ chain heterodimer. J Exp Med 165:1076, 1987
13. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Bluestone JA, Blazar BR: Lethal murine graft-versus-host disease induced by donor γ/δ expressing T cells with specificity for host nonclassical MHC class Ib antigens. Blood 87:827, 1996
14. Drobyski WR, Ash RC, Casper JT, McAuliffe T, Horowitz MM, Lawton C, Keever C, Baxter-Lowe LA, Camitta B, Garbrecht F, Pietryga D, Hansen R, Chitambar CR, Anderson T, Flomenberg N: Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse, and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 83:1980, 1994
15. Kasai M, Iwamori M, Nagai Y, Okumura K, Tada T: A glycolipid on the surface of mouse natural killer cells. Eur J Immunol 10:175, 1980
16. Ting CC, Bluestone JA, Hargrove ME, Loh NN: Expression and function of asialo GM1 in alloreactive cytotoxic T lymphocytes. J Immunol 137:2100, 1986
17. Ferrara JL, Mauch P, Van Dijken PJ, Crosier KE, Michaelson J, Burakoff SJ: Evidence that anti-asialo GM1 in vivo improves engraftment of T cell-depleted bone marrow in hybrid recipients. Transplantation 49:134, 1990
18. Yu YY, Kumar V, Bennett M: Murine natural killer cells and marrow graft rejection. Annu Rev Immunol 10:189, 1992
19. Dent AL, Matis LA, Hooshmand F, Widacki SM, Bluestone JA, Hedrick SM: Self-reactive γδ T cells are eliminated in the thymus. Nature 343:714, 1990
20. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice. J Exp Med 134:83, 1971
21. Blazar BR, Hirsch R, Gress RE, Carroll SF, Vallera DA: In vivo administration of monoclonal antibodies or immunotoxins in murine recipients of allogeneic T-cell depleted marrow for the promotion of engraftment. J Immunol 147:1492, 1991
22. Ledbetter JA, Rouse RV, Spedding Micklem H, Herzenberg LA: T cell subsets defined by expression of Lyt-1, 2, 3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med 152:280, 1980
23. Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintans J, Loken MR, Pierres M, Fitch F: Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: Similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131:2445, 1983
24. Sarmiento M, Dialynas DP, Lancki DW, Wall KA, Lorber MI, Loken MR, Fitch FW: Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T-cell mediated cytolysis. Immunol Rev 68:135, 1981
25. Houlden BA, Matis LA, Cron RQ, Widacki SM, Brown GD, Pampeno C, Merulo D, Bluestone JA: A TCR γδ cell recognizing a novel TL-encoded gene product. Cold Spring Harb Symp Quant Biol 54:45, 1989
26. Kranz DM, Saito H, Disteche CM, Swisshelm K, Pravtcheva D, Ruddle FH, Eisen HN, Tonegwa S: Chromosomal locations of the murine T-cell receptor alpha-chain gene and the T-cell gamma gene. Science 227:941, 1985
27. Murphy WM, Kumar V, Cope JC, Bennett M: An absence of T cells in murine bone marrow allografts leads to an increased susceptibility to rejection by natural killer cells and T cells. J Immunol 144:3305, 1990
28. Blazar BR, Widmer MB, Taylor PA, Vallera DA: Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1α. Blood 80:1614, 1992
29. Unkless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979
30. d antigens on the surface of these cells. Transplantation 34:113, 1982
31. Haynes BF, Eisenbarth GS, Fauci AS: Human lymphocyte antigens: Production of a monoclonal antibody that defines functional thymus-derived subsets. Proc Natl Acad Sci USA 76:5829, 1979
32. Barrett TA, Delvy ML, Kennedy DM, Lefrancois L, Matis LA, Dent AL, Hedrick SM, Bluestone JA: Mechanism of self-tolerance of γ/δ T cells in epithelial tissue. J Exp Med 175:65, 1992
33. Tonegawa S, Berns A, Farr A, Ishida I, Ito K, Itohara S, Janeway CA Jr, Kanagawa O, Katsuki M, Kubo R, Lafaille J, Mombaerts P, Murphy D, Nakanishi N, Takagaki Y, Van Kaer L, Verbeek S: Diversity, development, ligands, and probable function of γδ T cells. Cold Spring Harbor Symp Quant Biol 54:31, 1989
34. Teitell M, Cheroutre H, Panwala C, Holcombe H, Eghtesady P, Kronenberg M: Structure and function of H-2 T (Tla) region class I MHC molecules. Crit Rev Immunol 14:1, 1994
35. b) by a mouse γδ T cell receptor. Cell 62:549, 1990
36. Shild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, Matis L, Draper RK, Chien H-Y: The nature of the major histocmpatibility complex recognition by γδ T cells. Cell 76:29, 1994
37. Moriwaki S, Korn BS, Ichikawa Y, Van Kaer L, Tonegawa S: Amino acid substitutions in the floor of the putative antigen-binding site of H-2T22 affect recognition by a γδ T-cell receptor. Proc Natl Acad Sci USA 90:11396, 1993
38. Weintraub BC, Jackson MR, Hedrick SM: γδ T cells can recognize nonclassical MHC in the absence of conventional antigenic peptides. J Immunol 153:3051, 1994
39. Heath WR, Krane KP, Mescher MF, Sherman LA: Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc Natl Acad Sci USA 88:5101, 1991
40. Trinchieri G: Biology of natural killer cells. Adv Immunol 47:187, 1989
41. Bancroft GJ: The role of natural killer cells in innante resistance to infection. Curr Opin Immunol 5:503, 1993
42. Kronenberg M: Antigens recognized by γδ T cells. Curr Opin Immunol 6:64, 1994
43. Bezouska K, Yuen C-T, O'Brien J, Childs RA, Chai W, Lawson AM, Drbal K, Fiserova A, Pospisil M, Feizi T: Oligosaccharide ligands for NKR-P1 protein activate NK cells and cytotoxicity. Nature 372:150, 1994
44. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer clones. Science 267:1016, 1995
45. Rembecki RM, Kumar V, David CS, Bennett M: Polymorphism of Hh-1, the mouse hemopoietic histcompatibility locus. Immunogenetics 28:158, 1988
46. Vidovic D, Roglic M, McKune K, Guerder S, MacKay C, Dembic Z: Qa-1 restricted recognition of foreign antigen by a gamma delta T-cell hybridoma. Nature 340:646, 1989
47. Nakata M, Smyth MJ, Norihisa Y, Kawasaki A, Shinkai Y, Okumura K, Yagita H: Constituitive expression of pore-forming protein in peripheral blood γ/δ T cells: Implications for their cytotoxic role in vivo. J Exp Med 172:1877, 1990
48. Koizumi H, Liu C-C, Zheng LM, Joag SV, Bayne NK, Holoshitz J, Young JD-E: Expression of perform and serine esterases by human γ/δ T cells. J Exp Med 173:499, 1991
49. Martin PJ: Donor CD8 cells prevent allogeneic marrow graft rejection in mice: Potential implications for marrow transplantation in humans. J Exp Med 178:703, 1993
50. Drobyski WR, Majewski D: γδ T cells prevent allogeneic marrow graft rejection in mice without causing graft-versus-host disease. Blood 86:572a, 1995 (abstr, suppl 1)
51. Spaner D, Cohen BL, Miller RG, Phillips RA: Antigen-presenting cells for naive transgenic γδ T cells: Potent activation by activated ab T cells. J Immunol 155:3866, 1995
52. Kindler V, Thorens B, de Kossodo S, Allet B, Eliason JF, Thatcher D, Farber N, Vassalli P: Stimulation of hematopoiesis in vivo by recombinant bacterial murine interleukin 3. Proc Natl Acad Sci USA 83:1001, 1986
53. Vallera DA, Blazar BR: T-cell depletion for graft-versus-host disease (GVHD) prophylaxis: A perspective on engraftment in mice and humans. Transplantation 47:751, 1989
54. + T lymphocytes. J Immunol 151:6043, 1993
55. Tatsumi Y, Pena JC, Matis L, Deluca D, Bluestone JA: Development of T cell receptor-γδ cells: Phenotypic and functional correlations of T cell receptor-γδ thymocyte maturation. J Immunol 151:3030, 1993
56. Haas W, Pereira P, Tonegawa S: Gamma/delta cells. Annu Rev Immunol 11:637, 1993